Skip to main content

Fact-Checking Claims From the First Democratic Debate: Live

Ten Democrats seeking the presidency tussled on a Miami stage Wednesday night in the opening debate of the 2020 campaign, with 10 more on tap Thursday.

A look at some of their statements and how they compare with the facts:

Tim Ryan: “The bottom 60% haven’t seen a raise since 1980. The top 1% control 90% of the wealth.”

THE FACTS: Those figures from the U.S. representative from Ohio exaggerate the state of income and wealth inequality. While few studies single out the bottom 60%, the Congressional Budget Office calculates that the bottom 80% of Americans have seen their incomes rise 32% since 1979. That is certainly lower than the doubling of income enjoyed by the top one-fifth of income earners. And the richest 1% possess 32% of the nation’s wealth, according to data from the Federal Reserve, not 90%.

More must-read stories from Fortune:

--Democratic debate watch parties--and drinking games--are a thing

--Meet the 2020 Democratic presidential candidates you've (probably) never heard of

--Issues that divide 2020 candidates going into the first Democratic debate

--These are the top-polling Democratic candidates

--The 2019 Democratic debate clashes you won't get to see

--What to know About the 2019 Democratic debate: start time, schedule, format



from Fortune https://ift.tt/2Ygd1bI
Labels:

Comments

Post a Comment

Popular posts from this blog

Photo finish: Crashing sales force Olympus to sell iconic camera business

Sometimes, the vicissitudes of capitalism force companies to exit the businesses for which they’re best known. Olympus, once a leading light in the photography industry, is now joining that list. On Wednesday, the company said it planned to quit its 84-year-old camera business. The imaging giant, known for its once-pervasive digital cameras, agreed to sell off the declining unit by year’s end. Japan Industrial Partners, a private equity firm best known for buying Sony’s struggling Vaio computer line in 2014, agreed to purchase the business. Terms of the deal were not disclosed. A glance at Olympus’s financial statements provides all the rationale for the divestiture; as at rival manufacturers, camera sales have plummeted over the past decade. For the fiscal year ended March 31, Olympus’s camera unit declined 10% versus the year prior to  ¥43.6 billion, or $407 million. The unit’s sales have collapsed by three-quarters from a decade ago, when the company brought in ¥175 billion, or $
Post a Comment
Read more

WHO says common steroids can slash death risk for the sickest coronavirus patients

Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism,  subscribe today . An old drug can learn new tricks during the coronavirus pandemic. That’s the main takeaway from the World Health Organization (WHO) in a new analysis of corticosteroids—a class of drugs which have existed for dozens of years and are far cheaper than new, experimental COVID treatments in development—suggesting that drugs like dexamethasone can slash the chances of COVID-19 related deaths by as much as 35% in the sickest patients. The WHO analysis of coronavirus drugs encompassed seven separate studies. And while an analysis of this sort—what’s called a “meta-analysis”—isn’t as rigorous as other types of trials like a randomized controlled study, the data are compelling. Corticosteroids have a very different action mechanism from many of the other coronavirus drugs in development. COVID-19 is a peculiar disease. Some who have been infected may be
Post a Comment
Read more